IRIS
IANNONE, Florenzo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 23.799
AS - Asia 9.021
EU - Europa 8.453
SA - Sud America 2.426
Continente sconosciuto - Info sul continente non disponibili 1.689
AF - Africa 378
OC - Oceania 16
Totale 45.782
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 23.341
SG - Singapore 3.832
IT - Italia 2.920
CN - Cina 1.893
BR - Brasile 1.879
FR - Francia 1.143
HK - Hong Kong 1.096
SE - Svezia 1.009
RU - Federazione Russa 886
DE - Germania 761
VN - Vietnam 591
FI - Finlandia 575
GB - Regno Unito 443
BD - Bangladesh 316
IN - India 287
CA - Canada 204
AR - Argentina 188
UA - Ucraina 169
ID - Indonesia 139
IQ - Iraq 135
TR - Turchia 121
MX - Messico 120
ZA - Sudafrica 100
PK - Pakistan 89
JP - Giappone 88
EC - Ecuador 86
CI - Costa d'Avorio 82
CO - Colombia 79
BE - Belgio 72
SA - Arabia Saudita 70
ES - Italia 69
VE - Venezuela 67
NL - Olanda 58
PL - Polonia 57
IE - Irlanda 55
AT - Austria 52
PH - Filippine 50
UZ - Uzbekistan 45
MA - Marocco 42
CL - Cile 35
PY - Paraguay 35
JM - Giamaica 33
MY - Malesia 30
CZ - Repubblica Ceca 28
LT - Lituania 28
TN - Tunisia 27
IR - Iran 24
KE - Kenya 24
EG - Egitto 21
JO - Giordania 21
PE - Perù 21
ET - Etiopia 20
CH - Svizzera 19
CR - Costa Rica 18
BO - Bolivia 17
NP - Nepal 17
EU - Europa 15
OM - Oman 15
AZ - Azerbaigian 14
KZ - Kazakistan 14
DZ - Algeria 13
TH - Thailandia 13
AM - Armenia 12
AU - Australia 12
HN - Honduras 12
PA - Panama 12
UY - Uruguay 12
AE - Emirati Arabi Uniti 11
NI - Nicaragua 11
PS - Palestinian Territory 11
RS - Serbia 11
IL - Israele 10
LB - Libano 10
BB - Barbados 9
BH - Bahrain 9
DK - Danimarca 9
DO - Repubblica Dominicana 9
PT - Portogallo 9
AL - Albania 8
BG - Bulgaria 8
KG - Kirghizistan 8
KR - Corea 8
SN - Senegal 8
HR - Croazia 7
MD - Moldavia 7
QA - Qatar 7
AO - Angola 6
RO - Romania 6
SI - Slovenia 6
SY - Repubblica araba siriana 6
TT - Trinidad e Tobago 6
BY - Bielorussia 5
GF - Guiana Francese 5
GR - Grecia 5
HU - Ungheria 5
TW - Taiwan 5
CG - Congo 4
EE - Estonia 4
GT - Guatemala 4
MM - Myanmar 4
Totale 44.012
Salva come PNG Salva come JPEG
Città #
Fairfield 2.591
Ashburn 2.345
Singapore 2.075
Woodbridge 1.846
Houston 1.419
Chandler 1.365
San Jose 1.306
Milan 1.096
Hong Kong 1.085
Seattle 1.083
Cambridge 936
Ann Arbor 922
Wilmington 816
Nyköping 800
Beijing 609
Council Bluffs 577
Jacksonville 431
Dallas 417
Lauterbourg 384
Rome 368
New York 324
Lawrence 323
Roxbury 311
Helsinki 301
Los Angeles 299
Munich 282
Nanjing 256
Bari 245
Des Moines 204
Santa Clara 202
São Paulo 182
Ho Chi Minh City 180
Princeton 176
Columbus 175
Inglewood 173
Boardman 168
Hanoi 126
Buffalo 123
Falkenstein 120
San Diego 118
London 114
Moscow 114
Brooklyn 112
Figino 104
Chicago 96
Abidjan 81
Dearborn 80
Turku 79
Paris 75
Shenyang 75
Jakarta 74
Brussels 71
Tokyo 68
The Dalles 62
Frankfurt am Main 60
Montreal 60
Rio de Janeiro 60
Hebei 59
Turin 59
Phoenix 56
Baghdad 54
Dublin 54
Atlanta 53
Dong Ket 52
Jiaxing 52
Denver 51
Nanchang 51
San Francisco 51
Johannesburg 50
Warsaw 49
Boston 47
Toronto 47
Belo Horizonte 45
Dhaka 43
Orem 42
Poplar 40
Brasília 39
Mexico City 39
Tianjin 39
Nuremberg 38
Tashkent 38
Changsha 36
Chennai 36
Naples 36
Lahore 35
Stockholm 35
Manchester 34
Redwood City 31
Shanghai 30
Bar Harbor 29
Guangzhou 29
Pune 29
Quito 29
Guayaquil 27
Bologna 26
Curitiba 26
Vienna 26
Campinas 25
Riyadh 25
Ankara 24
Totale 29.860
Salva come PNG Salva come JPEG
Nome #
Orofacial Manifestation of Systemic Sclerosis: A Cross-Sectional Study and Future Prospects of Oral Capillaroscopy 282
Explainable artificial intelligence for microbiome data analysis in colorectal cancer biomarker identification 242
A rare association of anti-alanine-transfer RNA synthetase (anti-PL12) syndrome and sporadic inclusion body myositis 237
Survival and prognostic factors from a multicentre large cohort of unselected Italian systemic sclerosis patients 233
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group 233
Safety of Long-Term Biologic Therapy in Rheumatologic Patients With a Previously Resolved Hepatitis B Viral Infection 210
Sarcopenia in Patients with Rheumatic Diseases: Prevalence and Associated Risk Factors 210
AB0836 Drug retention rate of the first tnf inhibitor in radiographic and non radiographic axial spondyloarthritis: data from a multicenter study 200
No changes in N-terminal pro-brain natriuretic peptide in a longitudinal cohort of patients with systemic sclerosis-associated pulmonary arterial hypertension on therapy with bosentan 197
Autophagy markers LC3 and p62 accumulate in immune‐mediated necrotizing myopathy 196
Correlation between serum amyloid-A and serum levels of proinflammatory cytokines in patients with Behçet's disease 195
A Case of Osteonecrosis of the Jaw in a Patient with Crohn's Disease Treated with Infliximab 193
Clinical, histologic and prognostic features of clinically amyopathic dermatomyositis 190
A Bayesian mixed treatment comparison of efficacy of biologics and small molecules in early rheumatoid arthritis 190
Basic characteristics of adults with periodic fever, aphthous stomatitis, pharyngitis, and adenopathy syndrome in comparison with the typical pediatric expression of disease 189
AB0618 A unique ultrasound pattern of adipose tissue in systemic sclerosis patients: a comparison with rheumatoid arthritis patients and healthy controls. two sides of adipose tissue involvement in systemic chronic inflammatory diseases 187
AB0065 Possible Interplay Between Serum Amyloid-A and Pro-Inflammatory Cytokines Into the Pathogenesis of Behçet's Disease 187
Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study 186
A false occult hepatitis B virus infection developed in a patient with psoriatic arthritis under infliximab and methotrexate therapy 185
AB0452 Changes in Lipoproteins Associated with Tocilizumab Treatment Do not Influence the Atherogenic Index of Plasma of Rheumatoid Arthritis Patients: Table 1 182
Anti-SAE dermatomyositis: clinical and histologic characteristics from a monocentric Italian cohort 181
Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behçet's disease 180
Obesity reduces the drug survival of second line biological drugs following a first TNF-α inhibitor in rheumatoid arthritis patients 180
AB0041 Serum Amyloid A Stimulates The Induction of Inflammatory Mediators in Monocytes from Behçet's Disease Patients: A Proof of Concept Study 178
Efficacy and safety profile of anti-interleukin-1 treatment in Behçet’s disease: a multicenter retrospective study 174
Retinal vessels thrombosis as onset manifestation of systemic sclerosis: 3 clinical cases 173
Evaluation of differences in carotid intima-media thickness in patients affected by systemic rheumatic diseases 173
Clinical spectrum time course in anti jo-1 positive antisynthetase syndrome: Results from an international retrospective multicenter study 173
Lipids and atherogenic indices fluctuation in rheumatoid arthritis patients on long-term tocilizumab treatment 172
Two-year survival rates of anti-TNF-α therapy in psoriatic arthritis (PsA) patients with either polyarticular or oligoarticular PsA 171
Mucocutaneous Involvement in Behçet's Disease: How Systemic Treatment Has Changed in the Last Decades and Future Perspectives 171
Nailfold capillaroscopy characteristics of antisynthetase syndrome and possible clinical associations: Results of a multicenter international study 171
Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: Premises, perils, and perspectives 170
Possible interplay between interleukin-15 and interleukin-17 into the pathogenesis of idiopathic inflammatory myopathies 170
Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases 169
Digital ulcers predict a worse disease course in patients with systemic sclerosis 169
Refractory knee giant cell tumor of the synovial membrane treated with intra-articular injection of Infliximab: A case series and review of the literature 168
SAT0216 Chest Ultrasound Signs of Interstitial Lung Disease in Systemic Sclerosis Patients: A Comparison between High Resolution Chest Computed Tomography Findings 168
Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis 166
Golimumab in real-life settings: 2 Years drug survival and predictors of clinical outcomes in rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis 165
Body mass does not affect the remission of psoriatic arthritis patients on anti-TNF-α therapy 165
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: Results from the GISEA register 164
Orofacial Manifestations and Temporomandibular Disorders of Sjogren Syndrome: An Observational Study 164
Effects and safety of rituximab in systemic sclerosis: An analysis from the European Scleroderma Trial and Research (EUSTAR) group 161
AB0369 Adult-onset still’s disease treatment predictors at 1-year follow-up in a single rheumatologic centre experience 160
ANTI-TNFA THERAPY IN PSORIATIC ARTHRITIS: DIFFERENT RATE OF REMISSION IN POLYARTICULAR AND OLIGOARTICULAR SUBSETS 160
Paradoxical mucocutaneous flare in a case of Behçet’s disease treated with tocilizumab 158
Lipid Profile of Rheumatoid Arthritis Patients Treated with Anti-Tumor Necrosis Factor-Alpha Drugs Changes According to Disease Activity and Predicts Clinical Response 156
Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: Results from a collaborative project of 11 European biologic registers 156
Leucocytoclastic vasculitis as onset symptom of ulcerative colitis 155
Autoimmunity and autoinflammation as the yin and yang of idiopathic recurrent acute pericarditis 155
Different switching rate of anti-TNF-α drugs in monotherapy and in combination with methotrexate in a cohort of rheumatoid arthritis patients in the real life 153
A comprehensive comparison between pediatric and adult patients with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenopathy (PFAPA) syndrome 153
Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet's disease-related uveitis: a multicenter retrospective observational study 153
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: a four-year follow-up study 153
Auditory involvement in Behcet’s disease: relationship with demographic, clinical, and therapeutic characteristics 153
AN UNWELCOME HOST IN THE PATHOGENESIS OF ARTHRITIDES 152
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: A EUSTAR prospective study 152
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients 151
THU0153 The effect of 5-years b-dmards treatment on different 10-years cardiovascular risk scores applied in rheumatoid arthritispatients 150
Chondrocytes treated with different shock wave devices 148
SAT0212 Pericardial Effusion Related To Systemic Sclerosis: A Possible Contribution of The Serum Levels of Adipokines and Interleukines 148
Perivascular and endomysial macrophages expressing VEGF and CXCL12 promote angiogenesis in anti-HMGCR immune-mediated necrotizing myopathy 148
ASSOCIATION OF SYSTEMIC SCLEROSIS AND PSORIATIC ARTHRITIS: A CASE REPORT 146
Tumor necrosis factor receptor-associated periodic syndrome managed with the couple canakinumab-alendronate 146
LIPID PROFILE OF RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ANTI-TNF-ALPHA DRUGS CHANGES ACCORDING TO DISEASE ACTIVITY RESPONSE 146
Peripheral and central nervous system correlates in fibromyalgia 146
Joint and tendon involvement predict disease progression in systemic sclerosis: A EUSTAR prospective study 145
Proinflammatory cytokines and antiskin autoantibodies in patients with inherited epidermolysis bullosa 144
Update on laser-evoked potential findings in fibromyalgia patients in light of clinical and skin biopsy features 144
Serum amyloid-A in Behçet's disease 143
Longterm clinical outcomes in 420 patients with psoriatic arthritis taking anti-tumor necrosis factor drugs in real-world settings 142
The profiling of axial spondyloarthritis patient candidate to a biologic therapy: Consensus from a Delphi-panel of Italian experts 142
Analysis of subchondral cortical plate and trabecular bone in osteoarthritis experimentally induced in goat tibia. Preliminary results 141
Improvement of renal function and disappearance of hepatitis B virus DNA in a patient with rheumatoid arthritis and renal amyloidosis following treatment with infliximab 141
PFAPA syndrome and Behçet’s disease: a comparison of two medical entities based on the clinical interviews performed by three different specialists 140
Ten-Year Retention Rate of Infliximab in Patients with Behçet's Disease-Related Uveitis 140
Generation of a core set of items to develop classification criteria for Scleroderma renal crisis using consensus methodology 137
Management of Small Vessel Vasculitides 137
Safety of etanercept and methotrexate in patients with rheumatoid arthritis and hepatitis C virus infection: A multicenter randomized clinical trial 137
The impact of patient heterogeneity and socioeconomic factors on abatacept retention in rheumatoid arthritis across nine European countries 136
FRI0110 Methotrexate monotherapy in real life: a drug survival analysis. comparison between very early arthritis and early arthritis cohorts 136
High rate of disease remission in moderate rheumatoid arthritis on etanercept therapy: Data from GISEA, the Italian biologics register 135
Certolizumab Pegol treatment in Behcet's disease with different organ involvement: A multicenter retrospective observational study 135
Evaluation of Serum Levels of Adipokines and Interleukines in Pericardial Effusion Related to Systemic Sclerosis 135
A convolutional neural network with transfer learning for automatic discrimination between low and high-grade synovitis: a pilot study 134
Obesity and Inflammation – Targets for OA Therapy 134
Early-onset sarcoidosis caused by a rare CARD15/NOD2 de novo mutation and responsive to infliximab: a case report with long-term follow-up and review of the literature 134
The Impact of Biologic Drugs on High-Density Lipoprotein Cholesterol Efflux Capacity in Rheumatoid Arthritis Patients 134
Diagnosis of latent tuberculosis and prevention of reactivation in rheumatic patients receiving biologic therapy: International recommendations 133
Untangling the web of systemic autoinflammatory diseases 133
Key facts and hot spots on tumor necrosis factor receptor-associated periodic syndrome 133
Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration 133
Critical regulation of Th17 cell differentiation by serum amyloid-A signalling in Behcet's disease 132
Splenic Infarction as Only Manifestation of Antiphospholipid Syndrome in a Patient With Rheumatoid Arthritis 132
Early Lupus Project: one-year follow-up of an Italian cohort of patients with systemic lupus erythematosus of recent onset 132
Drug survival on TNF inhibitors: 2003-2004 data from Italian National Register (GISEA Register) 131
A Machine Learning Approach to Predict Remission in Patients With Psoriatic Arthritis on Treatment With Secukinumab 130
Update on the profile of the EUSTAR cohort: An analysis of the EULAR Scleroderma Trials and Research group database 130
OP0129 Drug survival on anti-tnf-alpha in psoriatic arthritis patients with axial involvement and analysis of predictors 130
Totale 16.213
Salva come PNG Salva come JPEG
Categoria #
all - tutte 195.707
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 195.707
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.083 0 0 41 125 109 185 163 146 153 171 344 646
2022/20233.717 575 439 289 301 364 495 78 433 545 28 108 62
2023/20241.250 105 260 58 98 105 267 38 60 15 47 32 165
2024/20256.640 145 91 482 157 139 616 635 774 335 405 1.000 1.861
2025/202615.643 1.967 622 910 1.691 1.861 931 1.697 529 1.463 1.508 458 2.006
2026/20272.011 648 909 454 0 0 0 0 0 0 0 0 0
Totale 45.782